These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12488664)

  • 41. Emergence of nalidixic acid resistant Shigella dysenteriae type 1 in Thailand: an outbreak associated with consumption of a coconut milk dessert.
    Hoge CW; Bodhidatta L; Tungtaem C; Echeverria P
    Int J Epidemiol; 1995 Dec; 24(6):1228-32. PubMed ID: 8824867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of shigellosis among children exposed to cases of Shigella dysentery: a multivariate assessment.
    Ahmed F; Clemens JD; Rao MR; Ansaruzzaman M; Haque E
    Am J Trop Med Hyg; 1997 Mar; 56(3):258-64. PubMed ID: 9129527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid emergence of third-generation cephalosporin resistance in Shigella sp. isolated in Andaman and Nicobar Islands, India.
    Bhattacharya D; Purushottaman SA; Bhattacharjee H; Thamizhmani R; Sudharama SD; Manimunda SP; Bharadwaj AP; Singhania M; Roy S
    Microb Drug Resist; 2011 Jun; 17(2):329-32. PubMed ID: 21352076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA; Kanga JF; Kuhn RJ; Rubio TT; Spohn WA; Stevens JC; Painter BG; Thurberg BE; Haverstock DC; Perroncel RY; Echols RM
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single-dose ciprofloxacin for shigellosis in adults.
    Bhattacharya SK; Bhattacharya MK; Dutta D; Dutta P; Paul M; Sen D; Sarkar S; Saha A; Pal SC
    J Infect; 1992 Jul; 25(1):117-9. PubMed ID: 1522320
    [No Abstract]   [Full Text] [Related]  

  • 46. Empirical treatment of Shigella dysentery with trimethoprim: five-day course vs. single dose.
    Oldfield EC; Bourgeois AL; Omar AK; Pazzaglia GL
    Am J Trop Med Hyg; 1987 Nov; 37(3):616-23. PubMed ID: 3688315
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group [corrected].
    Iravani A; Tice AD; McCarty J; Sikes DH; Nolen T; Gallis HA; Whalen EP; Tosiello RL; Heyd A; Kowalsky SF
    Arch Intern Med; 1995 Mar; 155(5):485-94. PubMed ID: 7864704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial.
    Sandberg T; Skoog G; Hermansson AB; Kahlmeter G; Kuylenstierna N; Lannergård A; Otto G; Settergren B; Ekman GS
    Lancet; 2012 Aug; 380(9840):484-90. PubMed ID: 22726802
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic diversity and antibiotic resistance in Shigella dysenteriae and Shigella boydii strains isolated from children aged <5 years in Egypt.
    El-Gendy AM; Mansour A; Weiner MA; Pimentel G; Armstrong AW; Young SY; Elsayed N; Klena JD
    Epidemiol Infect; 2012 Feb; 140(2):299-310. PubMed ID: 21470441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nalidixic acid-resistant Shigella dysenteriae type I in KwaZulu-Natal.
    Karas JA; Pillay DG
    S Afr Med J; 1996 Jan; 86(1):93. PubMed ID: 8685796
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children.
    Varsano I; Eidlitz-Marcus T; Nussinovitch M; Elian I
    J Pediatr; 1991 Apr; 118(4 Pt 1):627-32. PubMed ID: 2007941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemic Shigella dysenteriae type 1 in Burundi: panresistance and implications for prevention.
    Ries AA; Wells JG; Olivola D; Ntakibirora M; Nyandwi S; Ntibakivayo M; Ivey CB; Greene KD; Tenover FC; Wahlquist SP
    J Infect Dis; 1994 May; 169(5):1035-41. PubMed ID: 8169388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonserotypeable Shigella dysenteriae isolated from a Dutch patient returning from India.
    Kuijper EJ; van Eeden A; de Wever B; van Ketel R; Dankert J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):553-4. PubMed ID: 9272399
    [No Abstract]   [Full Text] [Related]  

  • 54. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serotype distribution and antimicrobial susceptibility of Shigellae isolated from diarrhoeal patients in Yangon, Myanmar.
    Oo KN; Thida M
    J Diarrhoeal Dis Res; 1995 Sep; 13(3):180-2. PubMed ID: 8568195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment duration of febrile urinary tract infection: a pragmatic randomized, double-blind, placebo-controlled non-inferiority trial in men and women.
    van Nieuwkoop C; van der Starre WE; Stalenhoef JE; van Aartrijk AM; van der Reijden TJ; Vollaard AM; Delfos NM; van 't Wout JW; Blom JW; Spelt IC; Leyten EM; Koster T; Ablij HC; van der Beek MT; Knol MJ; van Dissel JT
    BMC Med; 2017 Apr; 15(1):70. PubMed ID: 28366170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ciprofloxacin for 2 or 4 weeks in the treatment of febrile urinary tract infection in men: a randomized trial with a 1 year follow-up.
    Ulleryd P; Sandberg T
    Scand J Infect Dis; 2003; 35(1):34-9. PubMed ID: 12685882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Antibiotic resistance of strains of Shigella dysenteriae and flexneri isolated in Tananarive and on the east coast of Madagascar].
    Cassel-Béraud AM; Coulanges P; Richard C; Vaslet I
    Bull Soc Pathol Exot; 1990; 83(1):31-6. PubMed ID: 2190702
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changing pattern of resistant Shiga bacillus (Shigella dysenteriae type 1) and Shigella flexneri in Bangladesh.
    Shahid NS; Rahaman MM; Haider K; Banu H; Rahman N
    J Infect Dis; 1985 Dec; 152(6):1114-9. PubMed ID: 3905980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Resistance of Shigella dysenteriae type 1 to ampicillin and other antimicrobial agents: strains isolated during a dysentery outbreak in a hospital in Mexico City.
    Olarte J; Filloy L; Galindo E
    J Infect Dis; 1976 May; 133(5):572-5. PubMed ID: 772132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.